2020 Eddie Ozzie Award Winner
Winner of Folio's 2020
Eddie & Ozzie Awards

2023 AVBCC Summit

October 18-20, 2023

New York Athletic Club, New York, NY

  • The Association for Value-Based Cancer Care (AVBCC) will once again be meeting in person at the New York Athletic Club. The live event will be invitation-only, limiting the number of guests to follow safety guidelines. There will be a virtual simulcast of the entire Summit for those who cannot join us in New York.

    The One Conference That Covers It All

    Join us for this exclusive invitational forum that provides invaluable time with more than 200 diverse experts representing every stakeholder of the cancer care ecosystem. Nearly 100% of attendees agreed the content, topics, sessions, and information were relevant and up-to-date.

    Top Reasons to Participate in the 2023 Summit

    • LEARN to stay competitive in the ever-changing field of oncology.
    • EXPLORE cutting-edge methodologies you can implement in your company or institution immediately.
    • ACCESS timely and accurate information from sources you can rely on.
    • GAIN insights from a diverse range of practitioners, pharmacists, payers, policymakers, and other key stakeholders.
    • NETWORK with nationally recognized thought leaders.

    Registration

    Please Note:
    The live event is available on a first come, first served basis due to limited capacity. Sponsors will be guaranteed the opportunity to attend live. The general public is encouraged to request an invite to join and will be notified when accepted.

    The AVBCC Summit continues to empower all oncology care professionals to maximize value in cancer care by focusing on clinical, cost, and access issues. Secure your seat at the table today!

  • Take a look at the exciting lineup for the 2023 Summit! Sessions feature experts and respected faculty from across the field. This is a must-attend event for all stakeholders in the cancer-care value equation. Secure your spot today!

    • Wednesday, October 18

      8:00am - 8:50am

      The Future of Value-Based Care and Implications for US Healthcare

      Moderator:

      Linde Wilson, MBA
      Managing Partner, HealthQuest Advisors

      Faculty:

      Blair Childs
      President & CEO, Childs & Associates

      Digital Healthcare Technology: A Robust Growth Sector

      Moderator:

      Stan Kachnowski, PhD, MPA
      Director, Digital Health Program, Columbia Business School

      Faculty:

      Meg Barron
      Managing Director, Engagement & Outreach
      Peterson Center on Healthcare
      Ryan Huey, MD
      Department of Gastrointestinal Medical Oncology,
      Division of Cancer Medicine, MD Anderson
      Chevon Rariy, MD
      Chief Health Officer, Oncology Care Partners
      Christopher Merlan
      Chief Digital Officer & EVP, ASCO

      Warranties and Reinsurance to Manage Risk: Pharma and Provider Solutions

      Moderator:

      John Doyle, DrPH, MPH
      Group VP, Exponent

      Faculty:

      Scott Kornhauser
      CEO, KlearTrust
      Barbara McAneny, MD
      Past President, American Medical Association; Chair,
      National Cancer Care Alliance; CEO,
      New Mexico Cancer Center
      Brian Kern, Esq.
      Partner, Arcadia
      Brooks Wildasin
      Co-Founder & Chief Underwriting Officer, OutcomeRx
      Matt Hurlburt, MHA
      Head, Global Healthcare Innovation Center, Pfizer

      End of Life: Have We Made Improvements to this Legacy Issue?

      Moderator:

      William McGivney, PhD
      Managing Partner, McGivney Global Advisors

      Faculty:

      Marnie Kershner, CScD, CCC-SLP, BCS-S
      Senior Speech Pathologist, Medstar National Rehabilitation Hospital
      Afsaneh Barzi, MD, PhD
      Medical Director – GI Oncology, City of Hope
      Ramy Sedhom, MD
      Medical Oncologist and Palliative Medicine, Penn Medicine
      Roberto Ochoa Planchart, MD
      Senior Medical Officer, The Oncology Institute
      9:00am - 9:50am

      IRA Impact: Pharma Translating Impact Over the Next 5 Years

      Moderator:

      Lindsay Bealor Greenleaf, JD
      Solution Leader, Federal and State Policy, ADVI Health

      Faculty:

      Arda Ural, MBA, PhD
      Americas Industry Markets Leader for Life Sciences
      and Healthcare, Ernst & Young LLP (EY)
      Annette Powers, MBA, PharmD
      VP for Global Market Access, Bristol Myers Squibb
      Mark Vineis
      Chief Market Access Officer, Novartis
      Randy Burkholder
      VP, Policy and Research, PhRMA

      Cell and Gene Therapy Access – Product Cycle, CMS Model, and Patient Support

      Moderator:

      Stephanie Hobbs
      Principal, ECG Consultants

      Faculty:

      Jie Zhang, PhD
      VP, Head of Global Value and Access, Cell & Gene, Novartis
      Michael Wong, MD, PhD, FRCPC
      Professor, Department of Melanoma Medical Oncology
      MD Anderson
      Caleb DesRoisiers
      Pharmaceutical and Managed Care Services Executive
      COPILOT Provider Support Services, Inc
      Ross Hoffman, MD
      Chief Medical Officer, Centene

      Revenue Cycle Policy and Trends

      Moderator:

      Barbara McAneny, MD
      Past President, American Medical Association
      Chair, National Cancer Care Alliance
      CEO, New Mexico Cancer Center

      Faculty:

      Ron DiGiaimo, MBA, FACHE
      Chairman of the Board
      Revenue Cycle Coding Strategies
      Parag Shah
      President, Practice Solutions, Integra Connect
      Anne Hubbard
      Director, Health Policy, ASTRO

      How ePRO Technology Benefit Cancer Patients

      Moderator:

      Barry Russo
      CEO, Center for Cancer and Blood Disorders

      Faculty:

      Hillary Cavanagh
      Director, Division of Ambulatory Payment Models,
      Center for Medicare & Medicaid Innovation
      Brad Hirsch, MD, MBA
      Head of Product & Implementation, Verily
      Shelley Davis, MSN, RNC, CCM
      VP, Clinical Strategy, Lightbeam Health Solutions
      Madelyn Trupkin Herzfeld, RN, BSN, OCN
      Founder & Vice-Chairman, carevive
      10:00am - 10:50am

      IRA Healthcare Industry: Translating Impact Over the Next 5 Years

      Moderator:

      Jayson Slotnik, JD, MPH
      Partner, Health Policy Strategies

      Faculty:

      Muna Tuna
      US Market Pricing and Reimbursement Leader
      Ernest & Young, LLP
      Luke Greenwalt
      Vice President and Lead
      Market Access Center of Excellence, IQVIA
      Jeff Allen, PhD
      President & CEO
      Friends of Cancer Research

      Value-Based Agreements in Oncology: What Cancer Care Practices are Doing in the Marketplace Today

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Sibel Blau, MD
      President/CEO at Quality Cancer
      Care Alliance (QCCA) Network
      James Gilmore, PharmD
      Chief Pharmacy and Clinical Services Officer, AON
      Daniel Virnich, MD, MBA, FACHE
      CEO, The Oncology Institute
      Ted Okon, MBA
      Executive Director, COA
      Jeffrey Scott, MD
      President & Chief Medical Officer
      Integra Connect
      Josh Eaves
      Chief Development & Strategy Officer
      Florida Cancer Specialists

      Cell and Gene Therapy and the Future Impact on Cancer Care

      Moderator:

      Phil Cyr
      Senior VP, Precision Value & Health

      Faculty:

      Lung-I Cheng
      VP, Cell and Gene Therapy, AmerisourceBergen
      Paul LaPorte, MD
      Medical Director, The Oncology Institute

      Oncology Drug Shortages

      Moderator:

      Kathy Oubre, MS
      CEO, Pontchartrain Cancer Center

      Faculty:

      David Senior, MPH
      Senior VP, Market Economics, Cencora
      (formerly AmerisourceBergen)
      Gina Guinasso, JD
      President, CivicaScript
      Kevin Congdon
      VP, Institutional Sales, Accord Healthcare
      Michael Ganio, PharmD, MD, FASHP
      Senior Director, Pharmacy Practice
      and Quality, ASHP
      11:00am - 11:50am

      IRA Providers: Translating Impact Over the Next 5 Years

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Debra Pratt, MD, PhD, MBA
      Executive Vice President, Policy and
      Strategic Initiatives, Texas Oncology
      Ted Okon, MBA
      Executive Director, COA
      David Senior, MPH
      Senior VP, Market Economics
      Cencora (formerly AmerisourceBergen)
      Jeff Patton, MD
      CEO, OneOncology & Executive
      Chairman of the Board, Tennessee Oncology

      Disparities and the Impact on Cancer Care

      Moderator:

      Sybil Green, JD, RPh, MHA
      Diversity and Inclusion Officer
      American Society of Clinical Oncology

      Faculty:

      Ricky Martin, MD, MPH
      Medical Director, DI, Tennessee Oncology
      Joe Baffone
      CEO & Co-Founder, Annexus Health
      Edith Mitchell, MD, MACP, FCPP, FRCP (London)
      Clinical Professor of Medicine and Medical Oncology
      Department of Medical Oncology
      Director, Center to Eliminate Cancer Disparities
      Associate Director, Diversity Affairs
      Sidney Kimmel Cancer Center at Jefferson
      Member, President's Cancer Panel
      116th President, National Medical Association

      Generative AI, Large Language Models in Personalized Medicine

      Moderator:

      Ira Klein, MD, MBA, FACP
      VP, Medical Affairs, Payer Relations, Tempus Labs, Inc.

      Faculty:

      Dennis Flannelly, MBA
      Head of Precision Medicine, Merck
      Michael Sherman, MD, MBA
      Venture Partner, RA Capital Management, L.P.
      Cory Wiegert
      COO, Integra Connect

      Understanding the Economics of the Oncology Drug Pricing Ecosystem

      Moderator:

      Kent Rogers, MBA
      Former Chief Customer Officer, EQRx;
      Former SVP, Industry Relations, OptumRx

      Faculty:

      Antonio Ciaccia
      CEO, 46brooklyn Research and 3 Axis Advisors
      Robert Popovian, PharmD, MS
      Founder, Conquest Advisors
      Eric Percher
      Senior Analyst, Pharma Supply Chain &
      Digital Health, Nephron
      12:30pm - 1:20pm

      Keynote with Scott Gottlieb, MD, Former Commissioner, FDA

      1:30pm - 2:20pm

      Improving the Collaboration Between Oncology Practices and the PBM Industry

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Lalan Wilfong, MD
      VP, Payer Relations and
      Practice Transformation, McKesson
      Mostafa Kamal
      CEO, Magellan Rx
      Jeff Patton, MD
      CEO, OneOncology & Executive
      Chairman of the Board, Tennessee Oncology

      Integrating Precision Medicine Data into Real-World Pathways and Clinical Utility

      Moderator:

      Lucio Gordan, MD
      Chief Medical Officer for Therapeutics and Analytics &
      Past President, Florida Cancer Specialists

      Faculty:

      James Hamrick, MD, MPH
      VP, Clinical Oncology
      Flatiron Health
      Paul LaPorte, MD
      Medical Director
      The Oncology Institute
      Lucy Langer, MS, MD
      National Medical Director
      Oncology and Genomics, UnitedHealthcare

      Succeeding in Value-Based Payment Arrangements: ASCO’s Patient Centered Cancer Care Certification Pilot

      Moderator:

      Stephen Grubbs, MD, FASCO
      VP, Care Delivery, American Society of Clinical Oncology

      Faculty:

      Brian Bourbeau, MBA
      Division Director, Practice Health,
      American Society of Clinical Oncology
      Sybil Green, JD, RPh, MHA
      Diversity and Inclusion Officer,
      American Society of Clinical Oncology
      Matthew Skelton, MD
      Medical Oncology/Hematology,
      Blue Ridge Cancer Care
      Chiara Batelli, MD
      Medical Oncology/Hematology,
      New England Cancer Specialists

      Oncology and Vertically Integrated Supply Channels

      Moderator:

      Doug Long
      VP, Industry Relations, IQVIA

      Faculty:

      Lisa Harrison, RPh
      SVP and President
      Specialty Distribution and Solutions
      AmerisourceBergen
      Anthony Pansy
      Executive Vice President
      Business Development
      FFF Enterprises
      Barry Brooks, MD, MBA
      Chairman P&T
      US Oncology Network
      2:30pm - 3:20pm

      Pharma’s Role and Participation in Value-Based Agreements

      Moderator:

      Basit Chaudry, MD, PhD
      Founder, Tuple Health

      Faculty:

      Ranjani Durham
      Senior VP and Head
      US Market Access, BMS
      Brian Morrissey, MBA
      VP, Oncology National
      Customer Group, Pfizer
      Eliott Zarrett
      AVP, Oncology Payer
      Access and Pricing, Merck
      Michael Valenta
      VP, Value, Access and Pricing
      Strategic Customer Group (SCG) at
      Johnson & Johnson

      Challenges in Transitioning to Value-Based Care

      Moderator:

      Jeffrey Scott, MD
      President & Chief Medical Officer
      Integra Connect

      Faculty:

      Joel White
      President & CEO
      Horizon Government Affairs
      Lalan Wilfong, MD
      VP, Payer Relations and
      Practice Transformation, McKesson
      Alti Rahman, MHA, MBA, CSSBB
      Chief Strategy and Innovation Officer
      American Oncology Network, LLC (AON)

      GPOs and Their Future Impact and Role in Cancer Care

      Moderator:

      Eric Percher
      Senior Analyst
      Pharma Supply Chain & Digital Health
      Nephron

      Faculty:

      Ginger Ertel, PharmD, MBA
      VP, Pharmacy Member Services, Vizient
      Rick Lozano
      SVP, Specialty GPOs, AmerisourceBergen
      Lisa Raff, PharmD, MSPharm, BCPS, BCOP
      VP, Pharmacy Services, OneOncology
      Jessica Daly, PharmD, MBA
      Group VP, Strategic Sourcing, Premier
      Geoffrey Snow
      VP, GPO Operations, McKesson

      Examining the Clinical, Quality and Cost Impact of Breaking Down Silos Between Medical & Pharmacy Care

      Moderator:

      Denali Cahoon, PharmD
      Chief Pharmacy and Operating Officer, House Rx

      Faculty:

      Joseph Leach, MD
      SVP & Chief Medical Officer
      Prime Therapeutics
      Wafa Samara, RPh, PharmD
      VP & Chief Pharmacy Officer
      City of Hope
      Joshua Cox, PharmD, BCPS
      Director of Pharmacy Services
      Dayton Physicians Network
      John Watson, PharmD
      Chief Growth Officer
      HealthStrategy, LLC
      3:30pm - 4:20pm

      Enhancing Oncology Model (EOM) Update

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Barbara McAneny, MD
      Past President, American Medical Association;
      Chair, National Cancer Care Alliance;
      CEO, New Mexico Cancer Center
      Lalan Wilfong, MD
      VP, Payer Relations and
      Practice Transformation, McKesson
      Bobby Green, MD
      Co-Founder, President &
      Chief Medical Officer, Thyme
      Alexandra Chong, PhD
      EOM Team Lead
      CMS Innovation Center

      Innovative Reimbursement Models Based on Outcomes and Services

      Moderator:

      Howard Kraft
      Chief Strategy and Innovation Officer, XO Health

      Faculty:

      Daniel Virnich, MD, MBA, FACHE
      CEO, The Oncology Institute
      Rhonda Henschel, MBA
      VP, Payer Relations, McKesson
      Aaron Lyss
      Senior Director
      Strategic Payer Relations
      OneOncology
      Joel Brill, MD
      Chief Medical Officer
      Predictive Health

      Pharma Value-Based Programs: What Worked, Failed and is the Future

      Moderator:

      Natalie Bedford
      Senior VP, CenterWell Specialty Pharmacy (Humana Specialty Pharmacy)

      Faculty:

      Gergana Zlateva, MPA, PhD
      VP & Business Unit Lead, Oncology,
      Patient & Health Impact, Pfizer
      John Fox, MD, MHA
      Senior Medical Director for the Americas,
      Market Access, Illumina
      John Doyle, DrPH, MPH
      Group Vice President, Exponent

      340B Programs: Current State

      Moderator:

      Sherri Faber, RPh, MHA
      President & CEO, 340B Compliance Partners

      Faculty:

      Shannon Burger, CPA
      CEO, Cempa Community Care
      Ted Slafsky
      Publisher & CEO, 340B Report
      Jackson Hammond
      Health Care Policy Analyst
      The American Action Forum
      Andrew Brownlee
      Director
      Berkley Research Group
      4:30pm - 5:20pm

      EOM: Understanding Why Providers Did Not Sign on to the CMS Program

      Moderator:

      Jeffrey Scott, MD
      President & Chief Medical Officer
      Integra Connect

      Faculty:

      Debra Pratt, MD, PhD, MBA
      Executive Vice President, Policy
      and Strategic Initiatives, Texas Oncology
      Barbara McAneny, MD
      Past President, American Medical Association;
      Chair, National Cancer Care Alliance;
      CEO, New Mexico Cancer Center
      Jeff Patton, MD
      CEO, OneOncology & Executive
      Chairman of the Board, Tennessee Oncology
      Barry Russo
      CEO, Center for Cancer
      and Blood Disorders

      Employers and the Impact on Cancer Care

      Moderator:

      Art Taft, MBA, MEng
      Managing Director, Medworks Consulting, LLC

      Faculty:

      Monte Masten, MD
      Chief Medical Officer
      MarshMcLennan Agency
      Lisa Comerose, RN
      VP, Clinical Operations
      MarshMcLennan Agency
      Chris Skisak
      Executive Director
      Houston Business Coalition on Health

      Personalized Medicine Cancer Therapy Management

      Moderator:

      Mark Hiatt, MD, MBA, MS
      Chief Medical Officer, RadSite
      Founder & CEO, Hiatt Advisory Services

      Faculty:

      Ira Klein, MD, MBA, FACP
      VP, Medical Affairs
      Payer Relations
      Tempus Labs Inc
      Nate Wade, PharmD, MSBA, BCOP
      Associate Director
      Clinical Oncology
      Flatiron Health
      Paul LaPorte, MD
      Medical Director
      The Oncology Institute
      Amar Das, MD, PhD, FACMI
      Real World Evidence
      Guardant Health
      Jerry Mitchell, MD, MBA
      Director, Field Medical Oncology
      Foundation Medicine

      The Economic Realities of Cancer Site of Care

      Moderator:

      Connie Sullivan, BSPharm
      President & CEO, National Home Infusion Association

      Faculty:

      Lee Blansett, MBA
      EVP, HMP Market Access Insights
      John Hennessy, MBA
      Principal, Valuate
      Tory Wolff
      Managing Partner, Recon Strategy
      Pete Scruggs
      Founder, benefitSMART
      5:20pm - 6:00pm

      Beyond EOM: How does Health Equity Fit in Multi-Stakeholder Value-Based Care Partnership

      Moderator:

      Alti Rahman, MHA, MBA, CSSBB
      Chief Strategy and Innovation Officer
      American Oncology Network, LLC (AON)

      Faculty:

      John Sargent, MD
      Founding Partner, BroadReach
      Susan Sabo Wagner MSN, RN, OCN,
      Vice President, Clinical Innovation,
      American Oncology Network
      Barbara McAneny, MD
      Past President, American Medical Association;
      Chair, National Cancer Care

      Future Models of Precision Medicine

      Moderator:

      Bruce Quinn, MD, PhD
      Principal, Bruce Quinn Associates LLC

      Faculty:

      Ira Klein, MD, MBA, FACP
      VP, Medical Affairs & Payer Relations, Tempus
      Stan Skrzypczak, MS, MBA
      Managing Partner, 5Prime Life Science Consulting, Inc.
      Navid Alipour, JD, MBA
      CEO & Co-Founder, CureMatch
      Mark Hiatt, MD, MBA, MS
      Chief Medical Officer, RadSite
      Founder & CEO, Hiatt Advisory Services
    • Thursday, October 19

      8:00am - 8:50am

      Building the Conglomerates of Oncology Practice: Consolidation, Competition, and Care

      Moderator:

      Nick Ferreyros
      Managing Director
      Policy, Advocacy, and Communications, COA

      Faculty:

      Nathan Walcker
      CEO, Florida Cancer Specialists
      Daniel Virnich, MD, MBA, FACHE
      CEO, The Oncology Institute of Hope and Innovation
      Sibel Blau, MD
      President/CEO at Quality Cancer
      Care Alliance (QCCA) Network
      Jeff Patton, MD
      CEO, OneOncology & Executive
      Chairman of the Board, Tennessee Oncology

      Oncology Pipeline Report

      Moderator:

      Cheryl Ann Allen, MBA, BS Pharm
      Founding Partner, Curatio Scientia Advisors

      Faculty:

      Kelly McAuliff, PharmD, BCOP, CSP
      Senior Clinical Manager, Oncology/Hematology, CVS Specialty
      Jeffrey Bockman, PhD
      Expert Advisor, Oncology
      Head of Oncology Center of Excellence & EVP
      Oncology Practice Head, Lumanity
      Doug Long
      VP, Industry Relations, IQVIA

      Cancer Moonshot Update

      Moderator:

      Greg Simon
      Co-Founder, IMX Health Exchange;
      CEO/CFO Intelligent Medicine Acquisition Corp. (IQMD)

      Payers Practicing Medicine? Medical Necessity, Prior Authorization, Patient Records, and More, Oh My!

      Moderator:

      William McGivney, PhD
      Managing Partner, McGivney Global Advisors

      Faculty:

      Barbara McAneny, MD
      Past President, American Medical Association;
      Chair, National Cancer
      Vishnukamal Golla
      Medical Director for Value Transformation, Evolent Health
      Barry Brooks, MD, MBA
      Chairman P&T, US Oncology Network
      Lucy Langer, MS, MD
      National Medical Director
      Oncology and Genomics
      UnitedHealthcare
      9:00am - 9:50am

      Observations and Trends in Cancer Care

      Moderator:

      Chevon Rariy, MD
      Chief Health Officer, Oncology Care Partners

      Faculty:

      Doug Long
      VP, Industry Relations, IQVIA
      Bruce Pyenson, FSA, MAAA
      Principal, Consulting Actuary, Miiliman

      Artificial Intelligence and the Impact on Care Delivery Outcomes

      Moderator:

      Alti Rahman, MHA, MBA, CSSBB
      Chief Strategy and Innovation Officer
      American Oncology Network, LLC (AON)

      Faculty:

      John Sargent, MD
      Founding Partner at BroadReach
      Tony Blau
      President & CEO, All4Cure
      Cory Wiegert
      COO, Integra Connect
      Andy Corts
      Chief Technology Officer
      OneOncology

      Evolution of Clinical Trials

      Faculty:

      Mark Lee
      Co-Founder, Npower
      Maurie Markman
      City of Hope
      Elizabeth Garrett-Mayer, PhD
      VP, Center for Reasearch and Analytics, ASCO
      Sibel Blau, MD
      President/CEO at Quality Cancer Care Alliance (QCCA) Network

      Align & Thrive: Matching Information Exchange with Financial Flows

      Moderator:

      Jack Salerno
      Managing Partner, SBD Partners, LLC

      Faculty:

      Brian Gockerman
      CEO, Unlimited Systems
      Jonathan Zimmerman
      CEO, Holon Solutions
      10:00am - 10:50am

      The Battle for Oncology Margin in US Drug Channels

      Moderator:

      Doug Long
      VP, Industry Relations, IQVIA

      Faculty:

      Adam Fein, PhD
      CEO, Drug Channels Institute

      Establishing Value for Pharmaceuticals

      Moderator:

      William McGivney, PhD
      Managing Partner, McGivney Global Advisors

      Faculty:

      Annette Powers
      VP for Global Market Access, Bristol Myers Squibb
      Daniel Ollendorf, PhD, MPH
      Director of Value Measurement & Global Health Initiatives,
      Center for the Evaluation of Value and Risk in Health (CEVR);
      Assistant Professor, Tufts University School of Medicine

      Cancer Vaccines a New Treatment Paradigm

      Moderator:

      Jeffrey Bockman, PhD
      Expert Advisor, Oncology
      Head of Oncology Center of Excellence & EVP
      Oncology Practice Head, Lumanity

      The Evolution of Patient Advocacy

      Moderator:

      Elizabeth Franklin, PhD, MSW
      Head, US Public Affairs and Patient Advocacy, Oncology, Sanofi

      Faculty:

      Trish Goldsmith
      CEO, CancerCares
      Afsaneh Barzi, MD, PhD
      Medical Director – GI Oncology, City of Hope
      Brenda Nevidjon, MSN, RN, FAAN
      CEO, Oncology Nursing Society
      Alan Balch, PhD
      CEO, Patient Advocate Foundation
      Lisa Lacasse, MBA
      President, American Cancer Society Cancer Action Network
      11:00am - 11:50am

      The Ever-Changing Relationships Between Regional and Community in Cancer Care

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Nathan Walcker
      CEO, Florida Cancer Specialists
      Sibel Blau, MD
      President & CEO, Quality Cancer Care Alliance Network;
      Medical Director, Northwest Medical Specialties
      Tim Kubal, MBA, MD
      Senior Medical Director, Moffitt Cancer Center

      Transforming the Oncology Practice Clinically and Financially

      Moderator:

      Jeffrey Scott, MD
      President & Chief Medical Officer
      Integra Connect

      Faculty:

      Nicole Chambers
      VP, Strategic Initiatives
      Annexus Health
      Alti Rahman, MHA, MBA, CSSBB
      Chief Strategy and Innovation Officer
      American Oncology Network, LLC (AON)
      Scotty Pepper
      VP Operations
      Population Health, Integra Connect

      Precision Medicine’s Role Ensuring Accurate Diagnosis and Treatment

      Moderator:

      John Fox, MD, MHA
      Senior Medical Director for the Americas, Market Access, Illumina

      Faculty:

      Lucy Langer, MS, MD
      National Medical Director
      Oncology and Genomics, UnitedHealthcare
      James Hamrick, MD, MPH
      VP, Clinical Oncology
      Flatiron Health
      Ira Klein, MD, MBA, FACP
      VP, Medical Affairs
      Payer Relations
      Tempus Labs Inc.
      Brian Bourbeau, MBA
      Division Director
      Practice Health
      American Society of Clinical Oncology

      The Evolution of the MIP and Influences Impacting Patient Care

      Moderator:

      Michael Reff, RPh, MBA
      Founder & Executive Director, NCODA

      Faculty:

      Stacey McCullough, PharmD
      Director
      Clinical & Corporate Strategy
      NCODA
      Joseph Leach, MD
      SVP & Chief Medical Officer
      Prime Therapeutics
      Emily Gentry, RN, BSN, OCN, HON-ONN-CG
      Executive Director
      Strategy & Operations
      AONN+
      Scott Freeswick, MS, PharmD
      VP & Chief Pharmacy Officer
      Memorial Sloan Kettering Cancer Center
      Brian Morrissey, MBA
      VP, Oncology National
      Customer Group, Pfizer
      12:30pm - 1:20pm

      Fireside Lunch – Value in Practice

      Moderator:

      Marianne Gandee
      VP, Patient Solutions & Alliances
      North America, Pfizer Oncology

      Faculty:

      Shanthi Sivendran, MD, MSCR, MBA
      SVP, Cancer Support
      American Cancer Society
      Alex Tabarrok, PhD
      Bartley J. Madden Chair in Economics
      Mercatus Center at George Mason University
      1:30pm - 2:20pm

      Payers and Future Value-Based Transformation

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Yale Podnos, MD
      Chief Medical Officer
      The Oncology Institute
      Lucy Langer, MS, MD
      National Medical Director
      Oncology and Genomics
      UnitedHealthcare
      Adam Myers, MD, MHCM, FACHE
      Former Chief Clinical Transformation Officer
      Blue Cross Blue Shield Association

      A View on Legislation and Policy Out of Washington Ahead

      Moderator:

      Jayson Slotnik, JD, MPH
      Partner, Health Policy Strategies

      Faculty:

      Nicolas Ferreyros
      Managing Director of Policy
      Advocacy, and Communications
      Community Oncology Alliance
      Jerrica Mathis, MSED
      Head of Federal Government Relations
      Cardinal
      Randy Burkholder
      VP, Policy and Research, PhRMA
      Shelly Mui-Lipnik, JD
      Head of Federal Government Relations
      Cencora (formerly AmerisourceBergen)

      Value-Based Agreements: Roadmap from Strategy to Design Through Implementation

      Moderator:

      John Doyle, DrPH, MPH
      Group Vice President, Exponent

      Faculty:

      Greg Gregory, PhD
      Vice President
      Managing Director
      PRECISIONadvisors
      Rhonda Henschel, MBA
      VP, Payer Relations, McKesson
      Dorothy Hoffman, MPP
      Executive Director
      Head of Global Immunology Policy
      Novartis
      Michael Lynch, CPA, MBA
      Head of Market Access Strategy
      Bayer Radiology Division

      The Essential to Achieving Success in Value-Based Care: Medically Integrated Pharmacies & Dispensaries

      Moderator:

      Tesh Khullar, MBA
      Co-Founder & President, HouseRxx

      Faculty:

      Aaron Lyss
      Senior Director
      Strategic Payer Relations
      OneOncology
      Alti Rahman, MHA, MBA, CSSBB
      Chief Strategy and Innovation Officer
      American Oncology Network, LLC (AON)
      Marci Conlin
      VP, Pharmacy Network Management
      Prime Therapeutics
      Sibel Blau, MD
      President/CEO at Quality Cancer
      Care Alliance (QCCA) Network
      2:30pm - 3:20pm

      IRA and the Regulator’s Role in Price Negotiations

      Faculty:

      Marianne Hamilton Lopez, PhD, MPA
      Duke Margolis Center for Policy, Duke University
      Daniel Ollendorf, PhD, MPH
      Director of Value Measurement & Global Health Initiatives,
      Center for the Evaluation of Value and Risk in Health (CEVR);
      Assistant Professor, Tufts University School of Medicine

      Healthcare Interoperability: Advancing the Data State of Play in Value-Based Oncology Care

      Moderator:

      Joel Brill, MD
      Chief Medical Officer, Predictive Health

      Faculty:

      Drew Ivan
      Chief Product & Strategy Officer, Rhapsody
      Kimberly Chaundy, MBA
      Associate Vice President Applications &
      Interoperability, Geisinger
      Brad Ryan
      Chief Growth Officer, NCQA
      Charlie Harp
      CEO, Clinical Architecture

      Biosimilars and Industry Observations: Future Sustainability

      Faculty:

      Harsher Singh, MBA
      SVP, Amneal Pharmaceuticals
      Lisa Raff, PharmD, MSPharm, BCPS, BCOP
      VP, Pharmacy Services
      OneOncology
      Neal Lambert
      Senior Director & Team Lead Pricing
      Strategy US Biosimilars, Pfizer
      Barry Brooks, MD, MBA
      Chairman P&T
      US Oncology Network
      3:30pm - 4:20pm

      Creating Collaborative Partnerships: Stakeholder Perspectives Between Pharma, Payers, and Providers

      Moderator:

      Rani Khetarpal, MBA
      VP, Strategic Partnerships, Moderna

      Faculty:

      Samyukta Mullangi, MD, MBA, MS
      Medical Oncology Director, Thyme Care
      Ranjani Durham
      Senior Vice President and Head, US Market Access, BMS
      Jeff Davis
      Executive Director National Channel, AstraZeneca
      Afsaneh Barzi, MD, PhD
      Medical Director – GI Oncology, City of Hope

      Unified Leadership Efforts to Address and Shape the Future of Cancer Care

      Moderator:

      Cliff Hudis, MD, FACP, FASCO
      CEO, ASCO

      Faculty:

      Nicolas Ferreyros
      Managing Director of Policy, Advocacy, and
      Communications, Community Oncology Alliance
      Alyssa Schatz
      Senior Director Policy & Advocacy, NCCN

      New Patient-Centric Cancer Care Models

      Moderator:

      Chevon Rariy, MD
      Chief Health Officer, Oncology Care Partners

      Faculty:

      Greg Orr, MBA
      Chief Operating Officer, Jasper Health
      Andrew Norden, MD, MPH, MBA
      Chief Medical Officer, OncoHealth
      Bobby Green, MD
      Co-Founder, President &
      Chief Medical Officer, Thyme
      Kent Locklear, MD
      Chief Medical Officer
      Lightbeam Health Solutions

      Pediatrics and Cancer Care

      Moderator:

      Jon Hamrick
      Partner, Curatio Scientia Advisors

      Faculty:

      Robyn Gartrell, MD
      Assistant Professor of
      Pediatrics, CUMC
      Andrew Kung, MD, PhD
      Chair of Pediatrics
      Memorial Sloan Kettering Cancer Center
      Stephen Speicher, MD, MS
      Head of Care Quality
      Flatiron Health
      Stan Skrzypczak, MS, MBA
      Managing Partner
      5Prime Life Science Consulting, Inc.
      4:30pm - 5:20pm

      Good and Bad: Washington and State Policy and Economics Impacting Healthcare

      Moderator:

      Jayson Slotnik, JD, MPH
      Partner, Health Policy Stategies

      Faculty:

      Joe Grogan, JD
      Fellow, USC Schaeffer Center;
      Former Assistant to the President,
      Director of the Domestic Policy Council

      Capital Markets View on Pharmaceutical Innovation and Value

      Moderator:

      Ipsita Smolinski, MBA, MPH
      Founder & Managing Director, Capitol Street

      Navigating Payer Complexities in Oncology Coverage, Impact of Value Contracting & Ensuring Providers Understand Patient Access Implications

      Moderator:

      Charles Stevens, JD, MBA
      CEO, COPILOT Provider Support Services

      Faculty:

      John Hennessy, MBA
      Principal, Valuate Health Consultancy
      Susan Raiola
      President, Real Endpoints
      David Schmidt
      Head of US Growth, RxPx
      Sumner Madden
      Executive Director
      US Patient Support
      AstraZeneca
      Ela Lourido, MBA
      VP and General Manager
      Specialty Pharmacy Solutions

      Transparent PBM Models

      Moderator:

      Bob Charles, MBA
      Independent Strategy Consultant

      Faculty:

      Ethan Davidoff
      Founder & CEO
      Atlas Health
      Greg Baker, RPh
      CEO, AffirmedRx
      Sunil Budhrani, MD
      Chief Innovation & Medical Officer
      CapitalRx
      John Watson, PharmD
      Chief Growth Officer
      HealthStrategy, LLC
      5:20pm - 6:00pm

      Cancer Research and the Road Ahead

      Moderator:

      Rob Butcher
      President & CEO, Swim Across America

      Faculty:

      Steven Rosen, MD, FACP, FASCO, FAIMBE
      Provost and Chief Scientific Officer, City of Hope
      Jedd Wolchok, MD, PhD, FASCO
      Meyer Director of the Sandra and Edward Meyer
      Cancer Center, Weill Cornell Medicine
      Sam Urrutia, MD
      MD Anderson
      Nancy Daly, MS, MPH
      CEO, Conquer Cancer
      Mike Foote, MD
      Gastrointestinal Oncologist
      Memorial Sloan Kettering Cancer Center
      6:00pm - 9:00pm

      Reception Honoring Swim Across America surpassing the $120m Funding Ceiling for Cancer Research in 2023

    • Friday, October 20

      8:00am - 8:50am

      Practice Transformation Through Value-Based Analytics

      Moderator:

      Nina Chavez, MBA, FACHE
      VP, Customer Experience, Flatiron Health

      Faculty:

      Lalan Wilfong, MD
      VP, Payer Relations and
      Practice Transformation, McKesson
      Basit Chaudhry, MD, PhD
      Founder, Tuple Health
      Yale Podnos, MD, MPH, FACS
      Chief Medical Officer,
      The Oncology Institute of Hope and Innovation
      Jeffrey Scott, MD
      President & Chief Medical Officer
      Integra Connect

      Financial Toxicity

      Moderator:

      Angie Santiago
      Thomas Jefferson University Hospital
      & ACCC Financial Advocacy Network Chair

      Faculty:

      Lori Schneider
      Green Bay Oncology &
      ACCC Financial Advocacy Network
      Advisory Committee, Board of Trustee Member ACCC
      Rifeta Kajdic-Hodzic
      Oncology Education Program Manager at
      Association of Community Cancer Centers
      Clorinda Walley
      President, Happy Days

      The Impact of Inflation on the Healthcare Ecosystem

      Moderator:

      Chevon Rariy, MD
      Chief Health Officer, Oncology Care Partners

      Faculty:

      Thom Bales
      Principal, PricewaterhouseCoopers Advisory, LLC
      9:00am - 9:50am

      Primary Care Risk-Sharing Agreements with Specialty Cancer Care

      Moderator:

      Jeffrey Scott, MD
      President & Chief Medical Officer
      Integra Connect

      Faculty:

      Casey Rhode
      SVP, OneOncology
      Lalan Wilfong, MD
      VP, Payer Relations and Practice
      Transformation, McKesson
      Tim Barry
      Co-Founder & CEO
      VillageMD
      Daniel Virnich, MD, MBA, FACHE
      CEO
      The Oncology Institute
      Joel Brill, MD
      Chief Medical Officer
      Predictive Health

      Unlocking Innovation in Value-Based Care: Reflections on Current Policy Efforts Surrounding PBMs & Where Regulators Should Focus Next

      Moderator:

      Allison Canton, JD
      General Counsel, House Rx

      Faculty:

      Nicolas Ferreyros
      Managing Director of Policy
      Advocacy, and Communications
      Community Oncology Alliance
      Barbara McAneny, MD
      Past President
      American Medical Association
      Chair, National Cancer Care Alliance
      CEO, New Mexico Cancer Center
      Barry Brooks, MD, MBA
      Chairman P&T
      US Oncology Network
      Deborah Kamin, PhD, Rn
      VP, Policy & Advocacy, ASCO

      Specialty Oncology Pharmacy Networks

      Moderator:

      Bhavesh Shah, RPh, BCOP
      Chief Pharmacy Officer, Hematology/Oncology and
      Specialty Pharmacy, Boston Medical Center

      Faculty:

      Jorge Garcia, PharmD, MS, MHA, FACHE
      Assistant VP, System Oncology Pharmacy Service Line,
      Baptist Health South Florida
      Yen Nguyen, PharmD
      Executive Director of Pharmacy,
      Oncology Consultants
      Christie Smith, PharmD, MBA
      Senior Director, Payer Initiatives,
      Oncology Supply, an AmerisourceBergen Company
      Benito Fernandez
      MBA
      Chief Commercial Officer
      Onco360
      Crystal Lennartz, PharmD
      VP & GM
      McKesson
      Marci Conlin
      VP, Pharmacy Network Management
      Prime Therapeutics

      A Holistic Overview on the Real Cost of Cancer on Patients

      Moderator:

      Richard Brook
      President, Better Health Worldwide, Inc.

      Faculty:

      Chester ("Bernie") Good, MD, MPH
      Senior Medical Director Center for Value-Based
      Pharmacy Initiatives at UPMC Health Plan
      Davida Silverman
      Director, Oncology
      Public Policy & Reimbursement, Genentech
      10:00am - 10:50am

      Clinician Leadership Role in Transforming Cancer Care

      Moderator:

      David Johnson, MD, MPH
      Clinical Operating Partner, Rubicon Founders

      Faculty:

      Paul LaPorte, MD
      Medical Director
      The Oncology Institute
      Marcus Neubauer, MD
      Chief Medical Officer
      US Oncology

      AI and ML Decision Support Models

      Moderator:

      James Hamrick, MD, MPH
      VP, Clinical Oncology, Flatiron Health

      Faculty:

      Susan Weidner
      SVP
      Intrinsiq Specialty Solutions
      Jeffrey Becker, MBA
      VP, Business Development
      PRECISIONxtract
      Sagran Moodley
      Chief innovation Officer &
      Technology Officer, Ontada

      Surgical Oncology and the Impact and Role in Value-Based Agreements

      Moderator:

      Lawrence Wagman MD, FACS
      Clinical Professor, Div. Surgical Oncology, City of Hope

      Faculty:

      Yale Podnos, MD, MPH, FACS
      Chief Medical Officer, President of Practice,
      The Oncology Institute of Hope and Innovation

      Proactive Financial Assistance

      Moderator:

      Kathy Oubre, MS
      CEO, Pontchartrain Cancer Center

      Faculty:

      Niobis Queiro
      President & CEO, The Queiro Group
      Trish Goldsmith
      CEO, CancerCares
      Nick Jaidar, MHA, FACHE
      Director of Oncology Operations and
      Faculty Practice Administrator
      University of Maryland Greenbaum
      Comprehensive Cancer Center
      Tim L'Hommedieu, PharmD
      Senior Vice President
      Atlas Health
      11:00am - 11:50am

      Rise of MA Health Plan and Impact on Cancer Care

      Moderator:

      Jayson Slotnik, JD, MPH
      Partner, Health Policy Strategies

      Faculty:

      Hiram Satterwhite, FSA, CERA, MAAA
      Senior Consulting Actuary
      Milliman
      Ross Hoffman, MD
      Chief Medical Officer
      Centene

      How Do I Handle Bundle Payments

      Moderator:

      Barry Russo
      CEO, Center for Cancer and Blood Disorders

      Faculty:

      Lalan Wilfong, MD
      VP, Payer Relations and Practice
      Transformation, McKesson
      Alti Rahman, MHA, MBA, CSSBB
      Chief Strategy and Innovation Officer
      American Oncology Network, LLC (AON)

      Radiation Oncology: A New Approach and Model

      Moderator:

      Jordan Johnson, MSHA, iMpaCT
      Chief Innovation Officer, Oncospark

      Faculty:

      Arprit Chhabra, MD
      Director
      Education & Radiation Oncologist
      New York Proton Center
      Cheryl Turner. EdD, RT (R )(T)
      Director of Global Education & Training
      Legion Healthcare Partners
      Al Lawson, PhD
      SVP, Radiation Oncology
      Tennessee Oncology
      Jacob Philip
      CEO, MedLEver
      Join Luh, MD, FACP, FACR
      Radiation Oncologist
      Providence Health
      12:00pm - 12:50pm

      A Case for Sustaining Navigation the Economic Value and Metrics Behind Improving Outcomes and Quality of Life

      Moderator:

      Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
      Program Director, Academy of Oncology
      Nurse & Patient Navigators

      Faculty:

      Andi Dwyer, BS
      Program Director
      Colorado Cancer Screening Program
      Tricia Strusowski, MS, RN
      CEO & Co-Founder
      TurnKey Oncology
      Steven Peskin, MD, MBA, MACP
      Former Executive Medical Director
      Population Health and Transformation
      Horizon BCBS

      Addressing the Uncertainty of Cell and Gene Therapy’s Durability of Response through Novel Financing Arrangements

      Moderator:

      Joe DePinto
      Head of Cell, Gene & Advanced Therapies, McKesson

      Faculty:

      Herman Sanchez, MBA
      Chief Business Officer, Trinity Life Sciences
      Carlos Martin, MBA
      Chief Commercial Officer &
      Head of International, Rocket Pharma
      Chester Good, MD, MPH
      Senior Medical Director
      Center for Value-Based Pharmacy
      Initiatives at UPMC Health Plan

      Personalized Medicine

      Moderator:

      Van Crocker, MBA
      President, Agonist Health

      Faculty:

      Dorothy Hoffman, MPP
      Executive Director
      Head of Global Immunology Policy
      Novartis
      Carolyn Magill, MBA
      CEO, Aetion
      Viraj Narayanan, MBA
      Chief Commercial Officer, Ontada
      Todd Johnson, MD
      Chief Growth Officer
      Aster Insights (formerly M2Gen)

      Drug/Biologic Development; To Market; To Out-License; To be Acquired

      Moderator:

      William McGivney, PhD
      Managing Partner, McGivney Global Advisors

      Faculty:

      Pat Fetaya
      Head of US Business Development
      Servier
      Alex Santini
      SVP & Head, Global and
      US Market Access
      Arvinas Inc.
      Vicki Vakiener
      Board of Director Member
      Arrowhead Pharmaceuticals
      1:00pm - 1:50pm

      The Rise of Concierge Benefit Managers and Impact on Cancer Care

      Moderator:

      Lalan Wilfong, MD
      VP, Payer Relations and Practice
      Transformation, McKesson

      Faculty:

      Dickon Waterfield
      Chief Commercial Officer, Employee Direct Healthcare

      The Voice and Rights of a Patient with Cancer

      Moderator:

      Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
      Program Director, Academy of Oncology Nurse & Patient Navigators

      Faculty:

      Lisa Lacasse, MBA
      President
      American Cancer
      Society Cancer Action Network
      Molly Bognar, MSN, RN
      Head of Clinical
      Jasper Health

      Addressing Burnout in the Oncology Industry

      Faculty:

      Liudmila Schafer, MD, FACP
      Medical Oncologist, Medical Oncologist,
      Mercy Health System St Louis

      Radiation Oncology: Under Clinical Pathways, Transparency, and with Risk Share

      Moderator:

      Jordan Johnson, MSHA, iMpaCT
      Chief Innovation Officer, Oncospark

      Faculty:

      Arprit Chhabra, MD
      Director
      Education & Radiation Oncologist
      New York Proton Center
      Cheryl Turner. EdD, RT (R )(T)
      Director of Global Education & Training
      Legion Healthcare Partners
      Al Lawson, PhD
      SVP, Radiation Oncology
      Tennessee Oncology
      Jacob Philip
      CEO, MedLEver

    *Agenda subject to change. Additional faculty to be announced.

  • Location

    New York Athletic Club
    180 Central Park South, New York, NY 10019

    AVBCC is excited to offer discounted room rates this year!

    Click Here for AVBCC Accommodations

    Transit Information

    SUBWAY LINES

    • W – N – Q – W
    • A, C, or 1 train to 59th Street – Columbus Circle

    NEAREST SUBWAY STATION

    • 57 Street Subway Station (7th Avenue & 57th Street)

    PARKING

    • GMC: 200 Central Park South (59th Street & 7th Avenue)
    • Icon Parking System: 125 West 58th Street (58th Street & 7th Avenue)
    • Icon Parking System: 157 West 57th Street (57th Street & 7th Avenue)

    Dress Code

    MEN

    • Business attire; jackets and ties are not required in most areas.
    • Slacks or khakis are permitted with collared dress shirts, which must be tucked in at all times.
    • Jackets and ties are required in the Main Dining Room and Cocktail Lounge.

    WOMEN

    • Suits, dresses, sweaters, blouses, skirts, and tailored pants are permitted.
    • Halter tops, leggings, and clothing that reveals midriffs remain prohibited.

    NOT PERMITTED (Men & Women)

    • Sneakers, athletic shoes, flip-flops, clogs, and canvas boating shoes.
    • Jeans and other denim wear, shorts, T-shirts, and athletic wear.

    Mobile Voice and Data Policy

    Mobile phones and devices are prohibited in all facilities of the Club except guest rooms, enclosed phone booths, and the Lobby Communication Center. This includes speaking on a cell phone, e-mailing, texting, games, reading, and Internet browsing on a mobile device. Conference attendees may use their device in the conference meeting space.

  • How to Sponsor the 2023 AVBCC Summit

    Sponsoring the AVBCC annual summit will provide you with the opportunity to identify qualified leads on the spot, build and develop business relationships, and have unprecedented networking opportunities.

    If you are interested in sponsoring the 2023 AVBCC Summit, please click the button below and submit an application by completing the form. Thank you.

    AVBCC Summit Sponsorship Application

    Who Should Sponsor?

    All Stakeholders in the Cancer Care Ecosystem

    • Oncologists and Hematologists
    • Nurses
    • Oncology Nurse Navigators
    • Pathologists and Geneticists
    • Pharmacists, Practice Administrators
    • Practice Managers
    • Patient Advocacy Organizations
    • Managed Care Organizations
    • Insurance Companies
    • Third-Party Payers
    • Integrated Health Delivery Systems
    • Cancer Centers of Excellence
    • Medical Directors, Pharmacy Directors
    • Investors, Pharmaceutical and Biotech

    Reasons Your Company Should Sponsor

    • Meet with decision makers from leading oncology institutions and payer organizations
    • Demonstrate innovative products and services
    • Position your company as an industry leader
    • Gain exposure to strategic decision makers
    • Expand business opportunities with existing customers
    • Establish strategic partnerships
  • 2023 AVBCC Summit FAQs

    When and where will the 2023 AVBCC Summit take place?

    The 2023 AVBCC Summit will take place on October 18-20, 2023 in person at the New York Athletic Club (NYAC) in New York, NY, with a virtual simulcast.

    Where can I find the schedule of events?

    Please see the Full Agenda, located here.

    Note the agenda is subject to change, please check back for updates.

    How can I register for the Summit?

    The in-person event in NYAC is on a first come, first served basis due to limited capacity per state guidelines. To register for the Summit, please visit the Overview tab to request your invite.

    How can I sponsor the Summit?

    If you are interested in sponsoring the event, please complete the sponsor information form on the Sponsors tab.

    How can I receive Summit updates?

    AVBCC will send e-mails periodically to update you on the agenda, event happenings, logistics and newsletters. Please make sure that the e-mail address, This email address is being protected from spambots. You need JavaScript enabled to view it., is in your safe senders list to ensure you are receiving all important information.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: